Synergia Medical is selected for the MedTech Innovator 2020 Accelerator & ShowcaseJune 22 2020
We are very proud to announce that we have been selected for the MedTech Innovator Annual Accelerator and Showcase program.Learn more
Sophie Baratte becomes Chair of the Board of Synergia MedicalFebruary 25 2020
Synergia Medical proudly announces the appointment of Mrs. Sophie Baratte as Chair of the Board.Learn more
First US patentOctober 14 2019
Synergia Medical just obtained its first patent in the United States for its optical energy neurostimulator.Learn more
Yves Jongen becomes Chairman of the Board ad interimJuly 26 2019
Yves Jongen, currently board member of Synergia Medical, succeeds Reinhard Krickl and becomes Chairman ad interim.Learn more
Synergia Medical obtains funding from the European Commission (Horizon 2020)July 18 2019
We are proud to share that our versatile neurostimulation technological platform will enjoy the support of Horizon 2020.Learn more
We are in the Accenture Innovation Awards 2018 Top 25October 11 2018
For the last couple of months the Accenture Innovation Awards (AIA) has brought us on a journey. Hereby we are proud to announce that our recent work has made it to the Top 25 Health innovators in the AIA competition!
A growing team!September 29 2017
We are proud to announce our team's growth with our tenth employee! Welcome to her.Learn more
Synergia Medical in Europe's 20 most promising HealthTech comapniesJune 20 2017
Synergia Medical was selected to be part of the 20 most promising European HealthTech companies.
Presentation pitch was held in front of lead European MedTech investors in Lausanne, Switzerland.
Welcome to Yves Jongen and Jacques van RijckevorselJune 1 2017
We are very pleased to announce that Yves Jongen and Jacques van Rijckevorsel have joined Synergia Medical's Board of directors.
First patent grantedJune 1 2017
Our patent "Photovoltaic Electrical Stimulation Device" has been granted by the European Patent Office.Learn more
New Director joining the BoardMay 1 2017
Wim Goemaere joins as new Board member, bringing an impressive financial background.Learn more
NEUROPV project green lightedApril 24 2017
1,1 million € of non-dillutive capital granted by the Walloon Region for our NEUROPV project.Learn more
Working prototypeDecember 28 2016
The first working prototype is completed and demonstrated to the company's shareholders.Learn more
Business angels join the teamSeptember 1 2015
A seed round of 2,5 mio € is closed with private investors.Learn more
ISO 13485 certificationMay 1 2015
In less than 12 months, DEKRA notified body grants the company quality system with the ISO 13485 certification.Learn more
First round of private investorsMarch 2 2015
The company is happy to announce its first round of private investors composed by 3F'sLearn more
Proof of concept is workingDecember 1 2014
Our first proof of concept using PV cells is gone out of the lab and is working. Congrats to the dev team!
First employeesSeptember 1 2014
In september 2014 our first two employees joined the team. Real work can now start!Learn more
Walloon Region to finance two R&D projectsMay 1 2014
VitalSyn and OptiStart R&D projects are financed by Région Wallonne's DGO6Learn more